Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Biotech Vaneck ETF (BBH)

Biotech Vaneck ETF (BBH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 476,623,300
  • Market Capitalization, $K 476,623
  • Shares Outstanding, K 2,997
  • 60-Month Beta 1.11
Trade BBH with:
  • Price/Earnings ttm 27.13
  • Annual Dividend & Yield 0.47 (0.30%)
  • Most Recent Dividend 0.472 on 12/23/19
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
151.72 +4.74%
on 09/24/20
169.70 -6.36%
on 10/13/20
+4.13 (+2.67%)
since 09/23/20
3-Month
150.62 +5.50%
on 09/10/20
171.91 -7.56%
on 07/28/20
-11.48 (-6.74%)
since 07/23/20
52-Week
112.03 +41.85%
on 03/23/20
178.10 -10.77%
on 07/20/20
+34.92 (+28.16%)
since 10/23/19

Most Recent Stories

More News
Moderna Expects COVID-19 Vaccine Data in November: ETFs to Gain

Positive comment on coronavirus vaccine progress from Moderna's (MRNA) CEO during The Wall Street Journal's annual Tech Live conference has gained investors attention and raised vaccine optimism.

IBB : 136.49 (+0.25%)
XBI : 117.63 (+0.50%)
BBH : 158.91 (-0.08%)
BTEC : 50.23 (+0.45%)
IDNA : 39.66 (+0.03%)
GERM : 28.65 (+0.56%)
Biotech ETFs to Shine on Coronavirus Antibodies Progress

With Regeneron Pharmaceuticals and Eli Lilly & Company requesting the FDA for an Emergency Use Authorization for their antibody therapy treatments, the biotech space is filled with optimism.

IBB : 136.49 (+0.25%)
XBI : 117.63 (+0.50%)
BBH : 158.91 (-0.08%)
PBE : 59.67 (+0.12%)
ARKG : 70.11 (+1.18%)
Biotech ETFs to Gain on Trump's COVID-19 Treatment Protocol

The progress in Trump's health condition and his treatment protocols are continuously under the purview of market participants and are impacting Wall Street movements.

IBB : 136.49 (+0.25%)
XBI : 117.63 (+0.50%)
BBH : 158.91 (-0.08%)
PBE : 59.67 (+0.12%)
ARKG : 70.11 (+1.18%)
Top-Performing Biotech ETFs Amid the Coronavirus Crisis

The race to introduce vaccine and treatment of coronavirus is opening up opportunities, making the biotech sector a prospective space for investments.

IBB : 136.49 (+0.25%)
XBI : 117.63 (+0.50%)
BBH : 158.91 (-0.08%)
ARKG : 70.11 (+1.18%)
Biotech ETFs in Focus as the COVID-19 Vaccine Race Intensifies

Johnson & Johnson's entry into the late-stage trials has increased optimism in the coronavirus vaccine development.

IBB : 136.49 (+0.25%)
XBI : 117.63 (+0.50%)
BBH : 158.91 (-0.08%)
FBT : 157.62 (+0.10%)
ARKG : 70.11 (+1.18%)
ETFs to Gain as AstraZeneca Resumes Coronavirus Vaccine Trial

AstraZeneca's resumption of the late-stage trials can revive investors optimism surrounding the coronavirus vaccine development.

IBB : 136.49 (+0.25%)
CNCR : 27.96 (+1.08%)
XBI : 117.63 (+0.50%)
PPH : 62.46 (+0.35%)
BBH : 158.91 (-0.08%)
How Will Biotech ETFs React to Vaccine Makers' Safety Pledge?

Nine vaccine developers have jointly pledged to observe high ethical standards in conducting clinical studies and manufacturing of vaccines.

IBB : 136.49 (+0.25%)
XBI : 117.63 (+0.50%)
BBH : 158.91 (-0.08%)
FBT : 157.62 (+0.10%)
ARKG : 70.11 (+1.18%)
Will Novavax ETFs Gain on Coronavirus Vaccine Progress?

Investors are closely tracking the progress in the coronavirus vaccine development amid the coronavirus outbreak.

IBB : 136.49 (+0.25%)
XBI : 117.63 (+0.50%)
BBH : 158.91 (-0.08%)
PTH : 143.87 (+0.07%)
DWAS : 63.90 (+0.87%)
GERM : 28.65 (+0.56%)
Biotech ETFs to Shine Bright on Coronavirus Vaccine Progress

AstraZeneca's initiation of a phase III study has heated up competition to bring a coronavirus vaccine to the markets.

AZN : 52.00 (+0.08%)
IBB : 136.49 (+0.25%)
XBI : 117.63 (+0.50%)
BBH : 158.91 (-0.08%)
FBT : 157.62 (+0.10%)
ARKG : 70.11 (+1.18%)
Moderna ETFs to Gain on New Positive COVID-19 Vaccine Data

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.

MRNA : 70.53 (-0.44%)
IBB : 136.49 (+0.25%)
CNCR : 27.96 (+1.08%)
XBI : 117.63 (+0.50%)
BBH : 158.91 (-0.08%)
BTEC : 50.23 (+0.45%)
IDNA : 39.66 (+0.03%)
GERM : 28.65 (+0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Fund Summary

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of...

See More

Key Turning Points

2nd Resistance Point 160.84
1st Resistance Point 159.87
Last Price 158.91
1st Support Level 158.06
2nd Support Level 157.22

See More

52-Week High 178.10
Last Price 158.91
Fibonacci 61.8% 152.86
Fibonacci 50% 145.07
Fibonacci 38.2% 137.27
52-Week Low 112.03

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar